Sofinnova grows medtech company-creation strategy by 30% with €82m Fund IV close
Monday, September 28, 2026 · first reported by AltAssets and 3 others
Sofinnova Partners closed MD Start Fund IV, its medtech company-creation strategy, at €82M (oversubscribed), representing a 30% increase in size versus Fund III.
- Firm
- Sofinnova Partners
- Fund
- MD Start Fund IV
- Size
- $90M
- Stage
- Final close
- Asset class
- Venture
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
4 sources- AltAssetsSofinnova grows medtech company-creation strategy by 30% with €82m Fund IV close
- Business WireSofinnova Partners Closes Oversubscribed €82 Million Sofinnova MD Start IV Fund to Create the Next Generation of Medtech Companies
- MedTech DiveSofinnova raises 82M euros to fund medtech startups
- via.ritzau.dkSofinnova Partners Closes Oversubscribed €82 Million Sofinnova MD Start IV Fund to Create the Next Generation of Medtech Companies
- DIG Ventures raises $120m third fund to target Europe’s AI infrastructure startupsAltAssets +1
- Sofia-based LAUNCHub Ventures secures €65 million first close of Fund III; targets €75 million+EU-Startups +4
- Stride Consumer grows fund 30% with $550m hard-cap close after four-month raiseAltAssets +1
- Forty.5 Ventures Closes a $30M First Fund to Move SEE Founders Onto the World StageThe Recursive
- SEC charges Meyer Global Management, CEO with defrauding investors in SpaceX pre-IPO fundPensions & Investments +1
- Two Google alumni raise $11.3M to back AI startups that enterprises will actually pay forTechCrunch +1